Human CD8+T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL

European Journal of Immunology

Volumn 35, Issue 6, 2005, Pages 1812-1821

  Bosque, Alberto ^a   Pardo, Julián ^a   Martínez Lorenzo, Ma José ^b   Lasierra, Pilar ^b   Larrad, Luis ^b   Marzo, Isabel ^a   Naval, Javier ^a   Anel, Alberto ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Apoptosis; CD4+ and CD8+ T lymphocytes; Growth arrest; Human

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD59 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; FAS ANTIGEN; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; BLAST CELL; CELL CYCLE G2 PHASE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; ENZYME REACTIVATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INHIBITION KINETICS; LIVING DONOR; LYMPHOBLAST; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SENSITIVITY ANALYSIS; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD3; ANTIGENS, CD59; APOPTOSIS REGULATORY PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; FAS LIGAND PROTEIN; G2 PHASE; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20844451628     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526046     Document Type: Article

References (43)

1. Steinman, R. M., Turley, S., Mellman, I. and Inaba, K., The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000. 191: 411-416.
2. Sakaguchi, S., Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 2000. 101: 455-458.
3. Van Parijs, L. and Abbas, A. K., Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998. 280: 243-248.
4. Krummel, M. F. and Allison, J. P., CTLA-4 engagement inhibits IL2 accumulation and cell cycle progression of resting T cells. J. Exp. Med. 1996. 183: 2533-2540.
5. Lenardo, M., Chan, F. K. M., Hornung, F., MacFarland, H., Siegel, R., Wang, J. and Zheng, L., Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 1999. 17: 221-253.
6. Russell, J. H., Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 1995. 7: 382-388.
7. Vignaux, F. and Golstein, P., Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 1994. 24: 923-927.
8. Dhein, J., Walczak, H., Bäumler, C., Debatin, K. M. and Krammer, P. H., Autocrine T cell suicide mediated by APO-1 (Fas /CD95). Nature 1995. 373: 438-441.
9. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
10. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S., Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994. 76: 969-976.
11. Rieux-Laucat, F., Le Deist, F. and Fischer, A., Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 2003. 10: 124-133.
12. Martínez-Lorenzo, M. J., Alava, M. A., Gamen, S., Kim, J. K., Chuntharapai, A., Piñeiro, A., Naval, J. and Anel, A., Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells. Eur. J. Immunol. 1998. 28: 2714-2725.
13. -/- mice. Nat. Immunol. 2003. 4: 255-260.
14. Monleón, I., Martínez-Lorenzo, M. J., Monteagudo, L., Lasierra, P., Taulés, M., Iturralde, M., Piñeiro, A., Larrad, L., Alava, M. A., Naval, J. and Anel, A., Differential secretion of Fas ligand- or APO2 ligand/TRAIL-carrying microvesicles during activation-induced death of human T cells. J. Immunol. 2001. 167: 6736-6744.
15. Martínez-Lorenzo, M. J., Anel, A., Gamen, S., Monleón, I., Lasierra, P., Larrad, L., Piñeiro, A., Alava, M. A. and Naval, J., Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 1999. 163: 1274-1281.
16. Hildeman, D. A., Mitchell, T., Teague, T. K., Henson, P., Day, B. J., Kappler, J. and Marrack, P. C., Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999. 10: 735-744.
17. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Bouillet, P., Strasser, A., Kappler, J. and Marrack, P., Activated T cell death in vivo mediated by proapototic Bcl-2 family member Bim. Immunity 2002. 16: 759-767.
18. Bosque, A., Pardo, J., Martínez-Lorenzo, M. J., Iturralde, M., Marzo, I., Piñeiro, A., Alava, M. A., Naval, J. and Anel, A., Downregulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL and of c-FLIP, Bim or Bcl-x isoform expression. J. Leukoc. Biol. 2005. In press.
19. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 1995. 377: 348-351.
20. + CTL. Eur. J. Immunol. 2001. 31: 2951-2959.
21. + T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 1996. 26: 2903-2910.
22. Sytwu, H. K., Liblau, R. S. and McDevitt, H. O., The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996. 5: 17-30.
23. Sobek, V., Balkow, S., Körner, H. and Simon, M. M., Antigen-induced cell death of T effectors cells in vitro proceeds via the Fas pathway, requires endogenous IFN-γ and is independent of perforin and granzymes. Eur. J. Immunol. 2002. 32: 2490-2499.
24. Nguyen, L. T., McKall-Faienza, K., Zakarian, A., Speiser, D. E., Mak, T. W. and Ohashi, P. S., TNFR1 and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur. J. Immunol. 2000. 30: 683-688.
25. Teh, H. S., Seebaran, A. and Teh, S. J., TNFR2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death. J. Immunol. 2000. 165: 4814-4821.
26. + T cells. Int. Immunol. 1996. 8: 675-681.
27. + T cells for accelerated suicide causes immune incompetence. J. Clin. Invest. 2003. 111: 1191-1199.
28. Raftery, M. J., Behrens, C. K., Müller, A., Krammer, P. H., Walczak, H. and Schönrich, G., Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion. J. Exp. Med. 1999. 190: 1103-1113.
29. Liu, Z. X., Govindarajan, S., Okamoto, S. and Dennert, G., Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J. Immunol. 2001. 166: 3035-3041.
30. Wei, C. H., Yagita, H., Masucci, M. G. and Levitsky, V., Different programs of activation-induced cell death are triggered in mature activated CTL by immunogenic and partially agonistic peptide ligands. J. Immunol. 2001. 166: 989-995.
31. Sandalova, E., Wei, C. H., Masucci, M. G. and Levitsky, V., Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proc. Natl. Acad. Sci. USA 2004. 101: 3011-3016.
32. + T lymphocytes. Int. Immunol. 2000. 12: 195-203.
33. + cells and inhibit CTL activity through CD8 ligation. Eur. J. Immunol. 2003. 33: 125-134.
34. Renno, T., Attinger, A., Locatelli, S., Bakker, T., Vacheron, S. and MacDonald, H. R., Apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J. Immunol. 1999. 162: 6312-6315.
35. Lünemann, J. D., Waiczies, S., Ehrlich, S., Wendling, U., Seeger, B., Kamradt, T. and Zipp, F., Death ligand TRAIL induces no apoptosis but inhibits activation of human autoantigen-specific T cells. J. Immunol. 2002. 168: 4881-4888.
36. Taylor, W. R. and Stark, G. R., Regulation of the G2/M transition by p53. Oncogene 2001. 20: 1803-1815.
37. 2) arrest and apoptosis. Mol. Cell. Biochem. 2003. 243: 113-122.
38. cip-1/WAF-1, which promotes apoptosis. J. Immunol. 2000. 164: 4032-4036.
39. Davidson, W. F., Haudenschild, C., Kwon, J. and Williams, M. S., TCR ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent. J. Immunol. 2002. 169: 6218-6230.
40. Miltenyi, S., Muller, W., Weichel, W. and Radbruch, A., High gradient magnetic cell separation with MACS. Cytometry 1990, 11: 231-238.
41. Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L. and Ashkenazi, A., Differential hepatocyte toxicity of recombinant APO2L/TRAIL versions. Nat. Med. 2001. 7: 383-385.
42. Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A. and Ashkenazi, A., Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996. 271: 12687-12690.
43. Gong, J., Traganos, F. and Darzynkiewicz, Z., A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 1994. 218: 314-319.